Frenchay Dysarthria Assessment 2 Edition
FDA-2- Measurement, differential description, and diagnosis of dysarthria
- PCTA distributes but does not publish this product.
Choose from our formats
-
Kits
Starter & complete kits, print & digital
1 option
From USD 215.05 -
Support materials
Manuals, stimulus books, replacement items & other materials
2 options
From USD 65.55 -
All products
All tests and materials offered for FDA-2
3 options
From USD 65.55
-
FDA-2 Complete Kit
12685 Qualification Level B -
FDA-2 Rating Forms (Qty 25)
12687 Qualification Level B -
FDA-2 Intelligibility Cards
12688 Qualification Level B
Overview
- Publication date:
- 2008
- Age range:
- 12 years to adult
- Qualification level:
- B
- Completion time:
- 20 minutes
- Administration:
- Individual
Product Details
The second edition of Frenchay Dysarthria Assessment (FDA-2) includes new powerful knowledge about motor speech disorders and their contribution to neurological diagnosis. This updated edition remains a well-established test for the measurement, differential description, and diagnosis of dysarthria. It can be used in research, as well as all clinical settings.
FDA-2 is quick and simple to administer, accurate, reliable, and cost-efficient. The client is rated on a number of simple performance tasks related to speech function. It is divided into eight sections:
- Reflexes - ratings for cough, swallow, and dribble/drool
- Respiration - ratings at rest and in speech
- Lips - ratings for at rest, spread, seal, alternate, and in speech
- Palate - ratings for fluids, maintenance, and in speech
- Laryngeal - ratings for time, pitch, volume, and in speech
- Tongue - ratings for at rest, protrusion, elevation, lateral, alternate, and in speech
- Intelligibility - ratings for words, sentences, and conversation
- Influencing Factors - includes hearing, sight, teeth, language, mood, posture, rate (words per minute), and sensation
The test results can be recorded on the FDA-2 Rating Form, indicating both the clients strengths and weaknesses. The Rating Form also allows the clinician to compare the clients performance across all the items. Normative data are reported for adults without dysarthria as well as patients with specific dysarthria associated with confirmed medical diagnoses.